Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

← Back to course page
Courses Login
AML Course 3 – Optimising outcomes in AML: The role of HCT

AML Course 3 – 3 Knowledge Check Questions

Charles Craddock

Charles Craddock

CBE, FRCP (UK), FRCPath, DPhil, FMedSci

University of Birmingham, Birmingham, United Kingdom

Naval Daver

Naval Daver

MD

The University of Texas MD Anderson Cancer Center, Houston, TX, United States

2 Modules

Watch Time: 30 minutes

Published: Jul 27 2023

0.5 Credit

Credits Expire: Jul 27 2024

AML Course 3 – Optimising outcomes in AML: The role of HCT AML Course 3 – 3 Knowledge Check Questions
Login
Login

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Amedco LLC
and The Video Journal of Hematological Oncology. Amedco LLC is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for
Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team. Amedco Joint Accreditation Provider Number: 4008163

PHYSICIANS (ACCME) CREDIT DESIGNATION STATEMENT 

Amedco LLC designates this material for a maximum of 0.50 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACKNOWLEDGEMENT OF FINANCIAL COMMERCIAL SUPPORT

This course is supported by medical educational support from Jazz Pharmaceuticals. The supporter has no influence over the production of the content.

The content of VJHemOnc is intended for healthcare professionals